HEATHER GILLESPIE: Open Payments
NPI 1144779604 · MALTA, OH. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$389 in 21 payments from 10 companies in 2025. Trend: 2023 $127 · 2024 $125 · 2025 $389
Food & beverage: $389
| Company | Payments | Amount |
|---|---|---|
| ABBVIE INC. | 7 | $131 |
| ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.) | 3 | $64 |
| Phathom Pharmaceuticals, Inc. | 2 | $49 |
| Paratek Pharmaceuticals, Inc. | 2 | $31 |
| Axsome Therapeutics, Inc. | 2 | $30 |
| Verona Pharma, Inc. | 1 | $25 |
| Boehringer Ingelheim Pharmaceuticals, Inc. | 1 | $15 |
| AstraZeneca Pharmaceuticals LP | 1 | $15 |
| Merck Sharp & Dohme LLC | 1 | $14 |
| PFIZER INC. | 1 | $14 |
Products named: QULIPTA, CAPLYTA, VOQUEZNA, XHANCE, Auvelity, Ohtuvayre, UBRELVY, LINZESS.
Industry payments across OH — which companies pay providers there.
